Brief: Revelation Bio Announces Preclinical Biomarker Data Supporting Activity Of REVTx-300

Revelation Biosciences

07/02/2023 14:18

Feb 7 (Reuters) - Revelation Biosciences Inc  REVB.O :
    * REVELATION BIOSCIENCES INC. ANNOUNCES PRECLINICAL
BIOMARKER DATA
SUPPORTING ACTIVITY OF REVTX-300
    * REVELATION BIOSCIENCES INC-PLANS TO SEEK PUBLICATION OF
FULL
RESULTS DURING 2023 FOR REVTX-300

Source text for Eikon:  ID:nBw7PJQmwa 
Further company coverage:  REVB.O 
 ((Reuters.Briefs@thomsonreuters.com;))